978,20 €
Deine Einschätzung
Regeneron Pharmaceuticals Inc. Aktie
Regeneron ist ein amerikanisches Biotechnologie-Unternehmen, das an der New Yorker Börse gelistet ist und unter dem Tickersymbol REGN gehandelt wird. Regeneron entwickelt und produziert biologische Medikamente und Therapien für eine Vielzahl von Krankheiten und Beschwerden, darunter Krebs, Augenkrankheiten, entzündliche Erkrankungen und Stoffwechselstörungen. Das Unternehmen hat mit einigen seiner Produkte einen großen Erfolg erzielt, wie z.B. mit dem Medikament Eylea zur Behandlung von altersbedingter Makuladegeneration. Regeneron hat seinen Hauptsitz in Tarrytown, New York, und beschäftigt mehr als 8.000 Angestellte weltweit.
Was spricht für und gegen Regeneron Pharmaceuticals Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Regeneron Pharmaceuticals Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals Inc. | -0,29 % | -3,05 % | -0,71 % | 48,10 % | 22,66 % | 97,82 % | 260,49 % |
Incyte Corp. | 0,87 % | 3,74 % | 2,37 % | 5,03 % | 6,70 % | -9,72 % | -15,41 % |
Exact Sciences | -0,57 % | 1,19 % | 2,55 % | -49,61 % | -37,21 % | -56,91 % | -58,22 % |
Amgen Inc. | 0,15 % | 0,41 % | 5,75 % | 44,36 % | 16,88 % | 46,80 % | 89,57 % |
Kommentare
News
![CPI Data Sparks Rally in Biotech Stocks: https://www.marketbeat.com/logos/articles/med_20240715071929_cpi-data-sparks-rally-in-biotech-stocks.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEhWYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e72f3b13512241325fe9269e941b19b6d92017b2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240715071929_cpi-data-sparks-rally-in-biotech-stocks.jpg?locale=de)
CPI Data Sparks Rally in Biotech Stocks
The biotech sector has significantly lagged behind the overall market and its leading sector, technology, year-to-date. However, following the release of the CPI data on Thursday, the biotech
![3 No-Brainer Stocks to Buy in July: https://g.foolcdn.com/editorial/images/782643/scientists-in-a-lab-monitor-microscope.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVBOYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--678080f64af3105f5e27a2d61134944f78c59900/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/scientists-in-a-lab-monitor-microscope.jpg?locale=de)
3 No-Brainer Stocks to Buy in July
July is for barbecues, fireworks, and vacations. Many people don't want to think too hard about anything. Three Fool.com contributors think they have solutions for those investors who don't want to
![3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years: https://g.foolcdn.com/editorial/images/777831/a-couple-sitting-and-using-a-laptop.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd0NqYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--09328c143764ed7232ed3ea30805d3a3f423b125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-couple-sitting-and-using-a-laptop.jpg?locale=de)
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
The Great Recession ended nearly 15 years ago. Buying stocks toward the end of an economic slowdown can lead to some oversize returns down the road since that usually means you're buying them at